Case Report
An Acquired Factor VIII Inhibitor in a Patient with HIV and HCV: A Case Presentation and Literature Review
Table 1
Comparison between a meta-analysis by Delgado et al. [
33], a case series by Collins et al. [
2], and our patient
.
| Characteristics | Delgado et al. [33] (2003) | Collins et al. [2] (2007) | Our patient (2013) |
| Number of patients | 249 | 154 | 1 | Age category (median) | 64 (range, 8–93) | 78 (range, 2–98) | 57 | Sex | Female: 55% | Female: 57.38
| Male | Underlying diagnosis | Malignancy Postpartum status Autoimmune disorders | None: 63.3% Autoimmune or collagen vascular disease: 16.7% Malignancy: 14.7 | HCV, HIV, LA, MGUS | FVIII level category at diagnosis (median) | 2 IU/dL (range, 0–30) | 4 IU/dL (range, <1–12 IU/dL) | <1 IU/dL | Inhibitor titer at diagnosis (median) | 10.0 BU/mL (range, 0.9–32,000) | 7.2 BU/mL (range, 1.4–219 BU/mL) | 230.4 BU/mL |
|
|